Samuel C. Blackman, Head of Research and Developme at Day One Biopharmaceuticals, Inc. (DAWN), sold 709 shares at $11.69 ($8K) on 2023-11-16, disclosed to the SEC on 2023-11-17.
Open-market sale of $8k DAWN by Head of Research and Developme. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| DAWN | SELL | 2024-11-12 | $751K | — | Filing → |
| DAWN | SELL | 2024-11-08 | $361K | — | Filing → |
| DAWN | SELL | 2024-11-04 | $8K | — | Filing → |